About Shensongyangxin capsule ventricular contraction clinical observation.docVIP

 PAGE \* MERGEFORMAT 9 About Shensongyangxin capsule ventricular contraction clinical observation Of: Huoyou Ping, Zhang Shulin, Wu Feng-phase Keywords:] Shensongyangxin capsule, ventricular arrhythmia October 2005 -2006 in July, I used Shensongyangxin capsule ventricular contraction, the effect is satisfied with the report are summarized below. 1 Clinical data 1.1 General Information All patients from the hospital in October 2005 -2006 hospitalized patients in July. The treatment group of 30 patients, 18 males and 12 females, aged 32 to 74 years (mean 65.12 + -8.48) years, duration of the shortest 7 months, up to 10 years, including simple arrhythmia in 8 cases, 9 cases of coronary heart disease, hypertension in 11 cases, 2 cases of pulmonary heart disease. control group of 30 patients, 16 males and 14 females, age 30 ~ 70 years (mean 66.63 + -9.87) years, duration of minimum of 5 months and a maximum of 15 years, of which 6 cases of simple cardiac arrhythmia, coronary heart disease in 12 cases, 9 cases of hypertension, heart disease, 1 case of endogenous fat. 2 groups were comparable baseline data. 1.2 Diagnostic criteria Ventricular contraction diagnostic criterion-referenced lt;lt;utility within SCIENCES “gt; [1] standards, TCM diagnostic criteria for reference lt;lt;Chinese new drug clinical research guidance Policy”gt; [2], in line with palpitation, card is the heart Deficiency , Heart and blood stasis syndrome in patients with deficiency of both. 1.3 Inclusion criteria Meet the above diagnostic criteria, and do not have the following exclusion criteria of patients. 1.4 Exclusion criteria The age of 18 years of age or 70 years of age, pregnancy or breast-feeding women, those with allergies, people with serious liver and kidney and hematopoietic system of primary disease, mental illness. 1.5 suspension test, off case, excluding cases and treatment Occurred in the treatment of primary progressive deterioration of di